These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 21994365)

  • 21. Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats.
    Rosen RF; Fritz JJ; Dooyema J; Cintron AF; Hamaguchi T; Lah JJ; LeVine H; Jucker M; Walker LC
    J Neurochem; 2012 Mar; 120(5):660-6. PubMed ID: 22017494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.
    Cirrito JR; May PC; O'Dell MA; Taylor JW; Parsadanian M; Cramer JW; Audia JE; Nissen JS; Bales KR; Paul SM; DeMattos RB; Holtzman DM
    J Neurosci; 2003 Oct; 23(26):8844-53. PubMed ID: 14523085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition.
    Yamamoto M; Horiba M; Buescher JL; Huang D; Gendelman HE; Ransohoff RM; Ikezu T
    Am J Pathol; 2005 May; 166(5):1475-85. PubMed ID: 15855647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
    Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
    Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.
    Antequera D; Vargas T; Ugalde C; Spuch C; Molina JA; Ferrer I; Bermejo-Pareja F; Carro E
    Neurobiol Dis; 2009 Oct; 36(1):42-50. PubMed ID: 19607917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of β-amyloid accumulation by reticulon 3 in transgenic mice.
    Araki W; Oda A; Motoki K; Hattori K; Itoh M; Yuasa S; Konishi Y; Shin RW; Tamaoka A; Ogino K
    Curr Alzheimer Res; 2013 Feb; 10(2):135-42. PubMed ID: 22742855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo.
    Lee EB; Zhang B; Liu K; Greenbaum EA; Doms RW; Trojanowski JQ; Lee VM
    J Cell Biol; 2005 Jan; 168(2):291-302. PubMed ID: 15642747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival of cultured neurons from amyloid precursor protein knock-out mice against Alzheimer's amyloid-beta toxicity and oxidative stress.
    White AR; Zheng H; Galatis D; Maher F; Hesse L; Multhaup G; Beyreuther K; Masters CL; Cappai R
    J Neurosci; 1998 Aug; 18(16):6207-17. PubMed ID: 9698314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic expression of β1 antibody in brain neurons impairs age-dependent amyloid deposition in APP23 mice.
    Paganetti P; Reichwald J; Bleckmann D; Abramowski D; Ammaturo D; Barske C; Danner S; Molinari M; Müller M; Papin S; Rabe S; Schmid P; Staufenbiel M
    Neurobiol Aging; 2013 Dec; 34(12):2866-78. PubMed ID: 23870837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.
    Yang J; Ji Y; Mehta P; Bates KA; Sun Y; Wisniewski T
    J Alzheimers Dis; 2011; 24(2):269-85. PubMed ID: 21239853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of Aβ seeds in APP null mouse brain.
    Ye L; Fritschi SK; Schelle J; Obermüller U; Degenhardt K; Kaeser SA; Eisele YS; Walker LC; Baumann F; Staufenbiel M; Jucker M
    Nat Neurosci; 2015 Nov; 18(11):1559-61. PubMed ID: 26352792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice.
    Petrushina I; Ghochikyan A; Mktrichyan M; Mamikonyan G; Movsesyan N; Davtyan H; Patel A; Head E; Cribbs DH; Agadjanyan MG
    J Neurosci; 2007 Nov; 27(46):12721-31. PubMed ID: 18003852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice.
    Ruiz-Riquelme A; Mao A; Barghash MM; Lau HHC; Stuart E; Kovacs GG; Nilsson KPR; Fraser PE; Schmitt-Ulms G; Watts JC
    Acta Neuropathol Commun; 2021 May; 9(1):83. PubMed ID: 33971978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways.
    Bartl J; Meyer A; Brendler S; Riederer P; Grünblatt E
    J Neural Transm (Vienna); 2013 Jan; 120(1):113-20. PubMed ID: 22782687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BACE/APPV717F double-transgenic mice develop cerebral amyloidosis and inflammation.
    Ozmen L; Woolley M; Albientz A; Miss MT; Nelboeck P; Malherbe P; Czech C; Gruninger-Leitch F; Brockhaus M; Ballard T; Jacobsen H
    Neurodegener Dis; 2005; 2(6):284-98. PubMed ID: 16909011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice.
    Balakrishnan K; Rijal Upadhaya A; Steinmetz J; Reichwald J; Abramowski D; Fändrich M; Kumar S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR
    Acta Neuropathol Commun; 2015 Jul; 3():41. PubMed ID: 26141728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.